Xudong Wu

Xudong Wu

Auto-generated profile, based on publicly available information

Xudong Wu

Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Science
Verified
Journal Article
Closed access
PDF file
XWXudong Wu
Xudong Wu
MSMarc Siggel
Marc Siggel
SOSergey Ovchinnikov
Sergey Ovchinnikov
WMWei Mi
Wei Mi
VSVladimir Svetlov
Vladimir Svetlov
TRTom A. Rapoport
Tom A. Rapoport
A close-up view of the retrotranslocon: Misfolded endoplasmic reticulum (ER) proteins are retrotranslocated into the cytosol, polyubiquitinated, and degraded by the proteasome in a process known as ER-associated protein degradation (ERAD). ERAD of misfolded luminal ER proteins (ERAD-L) is mediated by the Hrd1 complex, composed of the ubiquitin ligase Hrd1 and four additional proteins (Hrd3, Der1, Usa1, and Yos9). Wu et al. report a cryo–electron microscopy structure of the active Hrd1 complex from yeast and, based on this structure, developed a model for how substrates are recognized and retrotranslocated. They propose that Hrd3 and Yos9 jointly create a luminal binding site for misfolded glycoproteins. Hrd1 and Der1 form “half-channels” juxtaposed in a thinned section of the ER membrane, which allows a polypeptide loop of an ERAD-L substrate to move through it. Science , this issue p. eaaz2449

29 June 2022 in Nature
Verified
Journal Article
Open access
PDF file
PFPeiqiang Feng
Peiqiang Feng
XWXudong Wu
Xudong Wu
SESatchal K. Erramilli
Satchal K. Erramilli
Joao A PauloJoao A Paulo
Joao A Paulo
PKPawel Knejski
Pawel Knejski
TRTom A. Rapoport
Tom A. Rapoport
Peroxisomes are ubiquitous organelles that house various metabolic reactions and are essential for human health1–4. Luminal peroxisomal proteins are imported from the cytosol by mobile receptors, which then recycle back to the cytosol by a poorly understood process1–4. Recycling requires receptor modification by a membrane-embedded ubiquitin ligase complex comprising three RING finger domain-containing proteins (Pex2, Pex10 and Pex12)5,6. Here we report a cryo-electron microscopy structure of the ligase complex, which together with biochemical and in vivo experiments reveals its function as a retrotranslocation channel for peroxisomal import receptors. Each subunit of the complex contributes five transmembrane segments that co-assemble into an open channel. The three ring finger domains form a cytosolic tower, with ring finger 2 (RF2) positioned above the channel pore. We propose that the N terminus of a recycling receptor is inserted from the peroxisomal lumen into the pore and monoubiquitylated by RF2 to enable extraction into the cytosol. If recycling is compromised, receptors are polyubiquitylated by the concerted action of RF10 and RF12 and degraded. This polyubiquitylation pathway also maintains the homeostasis of other peroxisomal import factors. Our results clarify a crucial step during peroxisomal protein import and reveal why mutations in the ligase complex cause human disease.

2 September 2024 in Cell Research
Verified
Journal Article
Open access
PDF file
ASAilong Song
Ailong Song
XWXudong Wu
Xudong Wu
Dear Editor, Norepinephrine (NE), also known as noradrenaline, is an important neurotransmitter that plays crucial roles in the central nervous system, including the regulation of mood, memory, and alertness. It also functions as a key hormone in the whole body. In the brain, NE transporter (NET, encoded by the SLC6A2 gene), a Na + /Cl-dependent transporter, reuptakes released NE at neuron synapses, thus maintaining NE homeostasis. Due to the important functions of NET, many drugs targeting NET have been developed to treat various neurological disorders. 1 Despite previous efforts using NET surrogate to gain insights into the transport mechanism, 2 the specific recognition of NE and the mechanistic details of the transport process remain elusive. Moreover, the binding modes of several FDA-approved NET-selective inhibitors require further investigations to provide a solid model for future structurebased drug discovery. In this study, we report high-resolution cryo-EM structures of human NET (hNET) bound with different ligands in three distinct states: an NE-bound inward-open state, an NE-bound occluded state, and an outward-open state bound with inhibitors. These structures reveal intricate details of NE recognition and inhibitor binding, and highlight the significant involvement of water molecules in such recognition process. The comparison of conformations of three different states provides mechanistic insights into the transport process mediated by hNET. We first attached a FLAG-avi tag to the N-terminus of full-length hNET and an N-terminal truncated version, hNET (47-617), and then purified the proteins in the presence of different ligands. Some populations of purified proteins were found to be highly glycosylated (Supplementary information, Fig. S1a, b). The yield and purity of FLAG-avi-hNET (47-617) (denoted as hNETcryo) were better and hNETcryo exhibited similar transport activity for NE and displayed similar sensitivities to different inhibitors compared to wild-type (WT) hNET (Supplementary information, Figs. S2a, c and S3). Therefore, hNETcryo purified in detergent was used for further cryo-EM analysis. To facilitate cryo-EM studies, we performed nanobody screenings (details are provided in Supplementary information) and chose two hits after extensive validations. Nb_BF9, screened using NE-bound hNETcryo, did not interact with inhibitor-bound hNET (data not shown). Therefore, Nb_BF9 was only used to form a complex with hNETcryo_NE. Another hit Nb_BB4, obtained using reboxetine-bound hNET, can form complexes with hNETcryo_NE, hNETcryo_reboxetine, and hNET-cryo_atomoxetine (Supplementary information, Fig. S1c). These two nanobodies were able to attenuate the transport activity of NE (Supplementary information, Fig. S2b) while displaying selective binding properties, suggesting that they are conformation-specific binders.

18 March 2025 in Nature
Verified
Journal Article
Closed access
PDF file
JLJiaming Liang
Jiaming Liang
JSJunhui Shi
Junhui Shi
ASAilong Song
Ailong Song
MLMeihua Lu
Meihua Lu
KZKairan Zhang
Kairan Zhang
DMDan Ma
Dan Ma

30 December 2024 in Cell Host & Microbe
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
HKHuihui Kong
Huihui Kong
BCBingxin Chu
Bingxin Chu
QYQian Yang
Qian Yang
CLChaohui Lin
Chaohui Lin
ZZZeli Zhang
Zeli Zhang

10 February 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
DZDan Zhao
Dan Zhao
XWXudong Wu
Xudong Wu
TRTom A. Rapoport
Tom A. Rapoport
Misfolded glycoproteins in the endoplasmic reticulum (ER) lumen are translocated into the cytosol and degraded by the proteasome, a conserved process called ER-associated protein degradation (ERAD). In Saccharomyces cerevisiae, the glycan of these proteins is trimmed by the luminal mannosidase Mnl1 (Htm1) to generate a degradation signal. Interestingly, Mnl1 is associated with protein disulfide isomerase (Pdi1). Here we used cryo-electron microscopy, biochemical and in vivo experiments to elucidate how this complex initiates ERAD. The Mnl1–Pdi1 complex first demannosylates misfolded, globular proteins that are recognized through the C-terminal domain (CTD) of Mnl1; Pdi1 causes the CTD to ignore completely unfolded polypeptides. The disulfides of these globular proteins are then reduced by the Pdi1 component of the complex. Mnl1 blocks the canonical oxidative function of Pdi1, allowing it to function as a disulfide reductase in ERAD. The generated unfolded polypeptides can then be translocated across the membrane into the cytosol.